sulfamethoxazole has been researched along with Acantholysis Bullosa in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuntz, HD | 1 |
| Erbs, G | 1 |
| Thiel, H | 1 |
| Müller, FE | 1 |
| May, B | 1 |
| Beyne, B | 1 |
2 other studies available for sulfamethoxazole and Acantholysis Bullosa
| Article | Year |
|---|---|
[Hematologic and dermatologic side-effects of antibiotic therapy].
Topics: Aged; Agranulocytosis; Drug Combinations; Epidermolysis Bullosa; Female; Humans; Middle Aged; Sulfam | 1982 |
[Favorable effect of the sulfamethoxazole-trimethoprim combination on the evolution of congenital bullous epidermolysis of the dystrophic form].
Topics: Child, Preschool; Drug Combinations; Epidermolysis Bullosa; Humans; Male; Sulfamethoxazole; Trimetho | 1982 |